🌟 Louise Oni: Mid-Career Achievement Award
🌟 Aliza Thompson: Lifetime Achievement Award (joined virtually!)
Congratulations 🎉
Thank you for your excellence and real-life impact in #GlomerularDisease
@Tobias_B_Huber
#ISGD #ClinicalTrials #NephTwitte
🌟 Louise Oni: Mid-Career Achievement Award
🌟 Aliza Thompson: Lifetime Achievement Award (joined virtually!)
Congratulations 🎉
Thank you for your excellence and real-life impact in #GlomerularDisease
@Tobias_B_Huber
#ISGD #ClinicalTrials #NephTwitte
The future of clinical trials? 🔜
tobias-b-huber.bsky.social kidney.org
#ISGDCTS2026 #ISGD #ClinicalTrials #Nephrology
The future of clinical trials? 🔜
tobias-b-huber.bsky.social kidney.org
#ISGDCTS2026 #ISGD #ClinicalTrials #Nephrology
‼️ In post-transplant recurrent GN research, feasibility is not secondary. It is scientific rigor.
The rarity of a condition should never determine the quality of evidence! 🌟
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials
‼️ In post-transplant recurrent GN research, feasibility is not secondary. It is scientific rigor.
The rarity of a condition should never determine the quality of evidence! 🌟
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials
🤯 Brain capital, health span and more! By @JochenReiser, @MitchElkind, Mikele Epperly and Peter McCaffrey
tobias-b-huber.bsky.social utmbhealth.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🤯 Brain capital, health span and more! By @JochenReiser, @MitchElkind, Mikele Epperly and Peter McCaffrey
tobias-b-huber.bsky.social utmbhealth.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
Read the announcement: www.kidney.org/press-room/n...
Read the announcement: www.kidney.org/press-room/n...
ISGD 🤝 Qualified Health
The first AI-enabled research network!
The future is here.
We are the doers.
tobias-b-huber.bsky.social utmbhealth.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #AI #NephTwitter #Nephrology
ISGD 🤝 Qualified Health
The first AI-enabled research network!
The future is here.
We are the doers.
tobias-b-huber.bsky.social utmbhealth.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #AI #NephTwitter #Nephrology
🌎 New world for children with #GlomerularDisease! No more waiting 13+ years after adult drug approval 👋
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #ClinicalTrials #Nephrology #PediatricNephrology
🌎 New world for children with #GlomerularDisease! No more waiting 13+ years after adult drug approval 👋
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #ClinicalTrials #Nephrology #PediatricNephrology
If you're attending, which ones were your favorites? 🌟
If not, what research would you like to see? 🔎
tobias-b-huber.bsky.social
#ISGD #GlomerularDisease #ClinicalTrials #Nephrology
If you're attending, which ones were your favorites? 🌟
If not, what research would you like to see? 🔎
tobias-b-huber.bsky.social
#ISGD #GlomerularDisease #ClinicalTrials #Nephrology
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
tobias-b-huber.bsky.social
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
Investors help decide which mechanism becomes a medicine, by criteria scientists rarely see.
Uncomfortable? Worth hearing 🌟
#CTS2026 #ISGD #GlomerularDisease #Biotech #ClinicalTrials
tobias-b-huber.bsky.social
Investors help decide which mechanism becomes a medicine, by criteria scientists rarely see.
Uncomfortable? Worth hearing 🌟
#CTS2026 #ISGD #GlomerularDisease #Biotech #ClinicalTrials
tobias-b-huber.bsky.social
🤯 Groundbreaking partnership
isgd.bsky.social 🤝 glomcon.org
✨ The Centers of Excellence in #GlomerularDisease
tobias-b-huber.bsky.social Ali Poyan Mehr
#CoEGD #ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🤯 Groundbreaking partnership
isgd.bsky.social 🤝 glomcon.org
✨ The Centers of Excellence in #GlomerularDisease
tobias-b-huber.bsky.social Ali Poyan Mehr
#CoEGD #ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🔥 Amazing results presented by Jonathan Barratt on the PIONEER study for IgAN and pMN!
👇 Check below
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🔥 Amazing results presented by Jonathan Barratt on the PIONEER study for IgAN and pMN!
👇 Check below
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
Fantastic results presented by Matthew Renfrow! 🔥
🔛 The bidirectional influence between Gd-IgA1 and kidney outcomes!
tobias-b-huber.bsky.social CureGN
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #NephTwitter #Nephrology
Fantastic results presented by Matthew Renfrow! 🔥
🔛 The bidirectional influence between Gd-IgA1 and kidney outcomes!
tobias-b-huber.bsky.social CureGN
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #NephTwitter #Nephrology
Can you feel the excitement? 🌟
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
Can you feel the excitement? 🌟
tobias-b-huber.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
💥 Breaking barriers
🚀 From challenges to solutions
🌟 Bright and exciting future!
Follow us, stay tuned!
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
💥 Breaking barriers
🚀 From challenges to solutions
🌟 Bright and exciting future!
Follow us, stay tuned!
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🌟 Fantastic talk by Abigail Smith!
👉 The promising role of eGFR and proteinuria as surrogate markers in APOL1 kidney disease
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #NephTwitter #Nephrology
🌟 Fantastic talk by Abigail Smith!
👉 The promising role of eGFR and proteinuria as surrogate markers in APOL1 kidney disease
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #NephTwitter #Nephrology
🧩 Challenges, barriers and future solutions
Rob Brenner, @InrigJula, Jiahua Li guided by Uptal Patel
👇 Drop your questions below
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🧩 Challenges, barriers and future solutions
Rob Brenner, @InrigJula, Jiahua Li guided by Uptal Patel
👇 Drop your questions below
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
Which trial is best for which disease and context? 🔎
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #ClinicalTrials #NephTwitter #Nephrology
Which trial is best for which disease and context? 🔎
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #ClinicalTrials #NephTwitter #Nephrology
🌟 Brilliant by Brendon Neuen
Much needed analysis from a fantastic collaborative SLR/MA
🤯 Another simultaneous article! In press at Nature Medicine
Slides at clarity-igan.org
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nep
🌟 Brilliant by Brendon Neuen
Much needed analysis from a fantastic collaborative SLR/MA
🤯 Another simultaneous article! In press at Nature Medicine
Slides at clarity-igan.org
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nep
Bringing patients voice into clinical trials is crucial 🌟
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
Bringing patients voice into clinical trials is crucial 🌟
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
🌟 Hiddo Heerspink on finerenone in FSGS (FIND-CKD): see albuminuria and proteinuria 🔎
👉 https://journals.lww.com/jasn/pdf/10.1681/asn.0000001333~finerenone-in-patients-with-focal-segmental
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrial
🌟 Hiddo Heerspink on finerenone in FSGS (FIND-CKD): see albuminuria and proteinuria 🔎
👉 https://journals.lww.com/jasn/pdf/10.1681/asn.0000001333~finerenone-in-patients-with-focal-segmental
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrial